Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

85.7%

-0.8% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

67%

4 of 6 completed trials have results

Key Signals

4 with results

Enrollment Performance

Analytics

N/A

4(80.0%)

Phase 2

1(20.0%)

5Total

N/A(4)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT02380612Not ApplicableCompleted

ReCell® Combined With Meshed Skin Graft in the Treatment of Acute Burn Injuries

Role: collaborator

NCT03333941Completed

Continued Access to the Recell® Device for Treatment of Acute Burn Injuries

Role: collaborator

NCT03150407Not ApplicableCompleted

Use of J3 Bioscience Lubricating Intravaginal Ring VR101 to Relieve the Symptoms of Vaginal Dryness

Role: collaborator

NCT04288752Not ApplicableCompleted

Efficacy of VR101 as a Personal Lubricant

Role: collaborator

NCT01588249Not ApplicableTerminated

A Novel Formulation of Pasteurized Maple Cough Syrup Compared With Placebo on Nocturnal Cough and Sleep Quality in Infants With Upper Respiratory Infection

Role: collaborator

NCT00987649Completed

Ovarian Cancer Risk Estimation in Patients With Pelvic Mass

Role: collaborator

NCT01083875Phase 2Completed

Study to Determine the Effects Treatment With Amlexanox 0.5% Oral Rinse Solution on Oral Mucositis Associated With Radiation Therapy for Cancer of the Head and Neck Region

Role: collaborator

All 7 trials loaded